Skip header and navigation

Refine By

4 records – page 1 of 1.

The right to know about chemical hazards in Canada, 1982-2006.

https://arctichealth.org/en/permalink/ahliterature156967
Source
New Solut. 2008;18(2):233-43
Publication Type
Article
Date
2008
Author
Dave Bennett
Author Affiliation
daveandjoanne@mts.net
Source
New Solut. 2008;18(2):233-43
Date
2008
Language
English
Publication Type
Article
Keywords
Access to Information - legislation & jurisprudence
Canada
Disclosure - legislation & jurisprudence
Hazardous Substances
Humans
Information Services - legislation & jurisprudence
Occupational Exposure - legislation & jurisprudence
Occupational health - legislation & jurisprudence
Abstract
Traditionally in Canada, there are three health and safety rights: the right to participate (joint workplace health and safety committees); the right to refuse unsafe and unhealthy work; and the right to know about workplace hazards. By the end of the 1970s, the right to know had been established in law across Canada, but it was not enough to cover workplace chemical hazards in particular. The Workplace Hazardous Materials Information System (WHMIS) was a project set up by the Canadian federal government in 1982 to address the issue. This article tells the story of how labor got the progressive WHMIS agreement(1985) and how the agreement has been implemented in the following years.
PubMed ID
18511399 View in PubMed
Less detail

Privacy of pharmacy prescription records.

https://arctichealth.org/en/permalink/ahliterature178197
Source
CMAJ. 2004 Sep 28;171(7):711-2; author reply 712
Publication Type
Article
Date
Sep-28-2004

The confidentiality of patient and physician information in pharmacy prescription records.

https://arctichealth.org/en/permalink/ahliterature181323
Source
CMAJ. 2004 Mar 2;170(5):815-6
Publication Type
Article
Date
Mar-2-2004
Author
Dick E Zoutman
B Douglas Ford
Assil R Bassili
Author Affiliation
Department of Pathology and Molecular Medicine, Queen's University, 76 Stuart Street, Kingston, Ontario K7L 2V7, Canada. zoutman@cliff.path.queensu.ca
Source
CMAJ. 2004 Mar 2;170(5):815-6
Date
Mar-2-2004
Language
English
Publication Type
Article
Keywords
Access to Information - legislation & jurisprudence
Canada
Confidentiality - legislation & jurisprudence
Disclosure - legislation & jurisprudence
Drug Prescriptions
Humans
Informed Consent - legislation & jurisprudence
Medical Records Systems, Computerized - legislation & jurisprudence
Pharmacy
Physician-Patient Relations
Notes
Cites: JAMA. 2000 Jan 19;283(3):373-8010647801
Cites: J Law Med Ethics. 1997 Summer-Fall;25(2-3):98-110, 8211066504
Cites: CMAJ. 2000 Oct 31;163(9):1146-811079059
Cites: CMAJ. 2002 Aug 20;167(4):393-612197705
Cites: BMJ. 2003 Feb 15;326(7385):37312586673
Cites: CMAJ. 2003 Jul 8;169(1):5, 712847016
Cites: CMAJ. 1998 Oct 20;159(8):997-10169834730
Comment In: CMAJ. 2004 Sep 28;171(7):711-2; author reply 71215451823
PubMed ID
14993178 View in PubMed
Less detail

A nation's genes for a cure to cancer: evolving ethical, social and legal issues regarding population genetic databases.

https://arctichealth.org/en/permalink/ahliterature81982
Source
Columbia J Law Soc Probl. 2004;37(3):359-411
Publication Type
Article
Date
2004
Author
Hsieh Alice
Author Affiliation
Columbia Journal of Law and Social Problems, Columbia University, USA.
Source
Columbia J Law Soc Probl. 2004;37(3):359-411
Date
2004
Language
English
Publication Type
Article
Keywords
Access to Information - legislation & jurisprudence
Biological Specimen Banks - legislation & jurisprudence
Confidentiality - legislation & jurisprudence
Databases, Genetic - ethics - legislation & jurisprudence
Disclosure - legislation & jurisprudence
Estonia
Ethics Committees, Research
Family
Genetics, Population
Great Britain
Haplotypes - genetics
Human Genome Project
Humans
Iceland
Informed Consent - legislation & jurisprudence
Internationality
Presumed Consent - legislation & jurisprudence
Refusal to Participate - legislation & jurisprudence
Singapore
Abstract
The advent of the human genome sequence has focused research on understanding underlying genetic links to complex diseases such as cancer, asthma and heart disease. In the past few years, individual countries, such as Iceland, Estonia, Singapore and the United Kingdom, have created national databases of their citizens' DNA for comparative research. Most recently, an international consortium including Nigeria, Japan, China and the United States launched a $100 million project called the International HapMap to map the human genome according to haplotypes, blocks of DNA that contain genetic variation. Such population genetic databases present challenging ethical, social and legal issues, yet regulation of genetic information has developed sporadically, from region to region, without a consistent international standard. Without a clear understanding of the consequences of genetic research in terms of individual and community-wide discrimination and stigmatization, genetic databases raise concerns about the protection of genetic information. This Note provides a survey of the evolving landscape of population genetic databases as a legislative and public policy tool for national and international regulators. It compares different approaches to regulating the collection and use of population genetic databases in order to understand what areas of consensus are formulating a foundation for an international standard. As the first population genetics project that will span multiple countries for the collection of DNA, the International HapMap has the potential to become an influential standard for the protection of population genetic information. This Note highlights issues among the national databases and the HapMap project that raise ethical, social and legal concerns for the future and recommends further protections for both individual donors and community interests.
PubMed ID
16755693 View in PubMed
Less detail